JP2006525944A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525944A5
JP2006525944A5 JP2004570427A JP2004570427A JP2006525944A5 JP 2006525944 A5 JP2006525944 A5 JP 2006525944A5 JP 2004570427 A JP2004570427 A JP 2004570427A JP 2004570427 A JP2004570427 A JP 2004570427A JP 2006525944 A5 JP2006525944 A5 JP 2006525944A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004570427A
Other languages
English (en)
Japanese (ja)
Other versions
JP4601429B2 (ja
JP2006525944A (ja
Filing date
Publication date
Priority claimed from US10/714,066 external-priority patent/US7202259B2/en
Application filed filed Critical
Publication of JP2006525944A publication Critical patent/JP2006525944A/ja
Publication of JP2006525944A5 publication Critical patent/JP2006525944A5/ja
Application granted granted Critical
Publication of JP4601429B2 publication Critical patent/JP4601429B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004570427A 2002-11-18 2003-11-17 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体 Expired - Fee Related JP4601429B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42738102P 2002-11-18 2002-11-18
US46027803P 2003-04-03 2003-04-03
US48848803P 2003-07-17 2003-07-17
US10/714,066 US7202259B2 (en) 2002-11-18 2003-11-13 Therapeutic agents useful for treating pain
PCT/US2003/036742 WO2004046132A1 (en) 2002-11-18 2003-11-17 4-tetrazolyl-4phenylpiperidine derivatives for treating pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010056560A Division JP2010163452A (ja) 2002-11-18 2010-03-12 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体

Publications (3)

Publication Number Publication Date
JP2006525944A JP2006525944A (ja) 2006-11-16
JP2006525944A5 true JP2006525944A5 (https=) 2007-01-11
JP4601429B2 JP4601429B2 (ja) 2010-12-22

Family

ID=32777221

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004570427A Expired - Fee Related JP4601429B2 (ja) 2002-11-18 2003-11-17 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体
JP2010056560A Pending JP2010163452A (ja) 2002-11-18 2010-03-12 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010056560A Pending JP2010163452A (ja) 2002-11-18 2010-03-12 疼痛治療用4−テトラゾリル−4フェニルピペリジン誘導体

Country Status (36)

Country Link
US (3) US7202259B2 (https=)
EP (2) EP1562932B9 (https=)
JP (2) JP4601429B2 (https=)
KR (1) KR20050115221A (https=)
CN (2) CN100567288C (https=)
AP (1) AP2210A (https=)
AR (1) AR047008A1 (https=)
AT (2) ATE358674T1 (https=)
AU (2) AU2003294313B2 (https=)
BR (1) BR0316305A (https=)
CA (1) CA2506242C (https=)
CO (1) CO5690588A2 (https=)
CR (2) CR7877A (https=)
CY (2) CY1107682T1 (https=)
DE (2) DE60313021T2 (https=)
DK (2) DK1803718T3 (https=)
EA (1) EA008621B1 (https=)
EC (1) ECSP055840A (https=)
ES (2) ES2285235T3 (https=)
GE (1) GEP20084539B (https=)
IL (1) IL209352A0 (https=)
IS (2) IS2720B (https=)
MA (1) MA27565A1 (https=)
ME (1) MEP48108A (https=)
MX (1) MXPA05004669A (https=)
MY (1) MY135647A (https=)
NI (1) NI200500087A (https=)
NO (1) NO20052894L (https=)
NZ (2) NZ572685A (https=)
OA (1) OA13010A (https=)
PT (2) PT1803718E (https=)
RS (1) RS51047B (https=)
SG (1) SG165998A1 (https=)
SI (2) SI1562932T1 (https=)
TW (2) TWI343917B (https=)
WO (1) WO2004046132A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
RS20050812A (sr) 2003-04-30 2007-12-31 Purdue Pharma L.P., Transdermalni dozni oblik otporan na promene
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
KR100886002B1 (ko) 2004-01-30 2009-03-03 유로-셀띠끄 소시에떼 아노님 4-테트라졸릴-4-페닐피페리딘 화합물의 제조방법
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
PT1951718E (pt) * 2005-11-21 2012-05-21 Purdue Pharma Lp Compostos de 4-oxadiazolil-piperidina e as suas utilizações
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
WO2011056561A1 (en) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
ES2566828T3 (es) 2010-09-21 2016-04-15 Purdue Pharma L.P. Análogos de buprenorfina como agonistas y/o antagonistas del receptor opioide
CN102648915B (zh) * 2011-02-28 2015-04-15 鲁南制药集团股份有限公司 一种治疗或预防神经病理性疼痛的药物组合物
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
EP2917182B1 (en) 2012-11-09 2018-01-03 Purdue Pharma LP Benzomorphan analogs and the use thereof
WO2014087226A1 (en) 2012-12-07 2014-06-12 Purdue Pharma L.P. Buprenorphine analogs as opiod receptor modulators
WO2014091297A1 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Spirocyclic morphinans and their use
EP2931724B1 (en) 2012-12-14 2017-01-25 Purdue Pharma LP Pyridonemorphinan analogs and biological activity on opioid receptors
JP6182620B2 (ja) 2013-01-31 2017-08-16 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
WO2015097546A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Propellane-based compounds and their use as opioid receptor modulators
WO2015097547A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 10-substituted morphinan hydantoins
WO2015097548A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
EP3087057A4 (en) 2013-12-26 2017-06-28 Purdue Pharma LP Ring-contracted morphinans and the use thereof
WO2015099863A1 (en) 2013-12-27 2015-07-02 Purdue Pharma L.P. 6-substituted and 7-substituted morphinan analogs and the use thereof
CA2950567A1 (en) 2014-05-27 2015-12-03 Purdue Pharma L.P. Spirocyclic morphinans and use thereof
MA40171A (fr) 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés d'azamophinan et leur utilisation
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
US11529340B2 (en) 2016-03-22 2022-12-20 Regents Of The University Of Minnesota Combination for treating pain
UA124972C2 (uk) 2016-07-29 2021-12-22 Янссен Фармацевтика Нв Способи лікування раку передміхурової залози
WO2018125716A1 (en) 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
MX2023013514A (es) * 2021-05-21 2024-04-02 Purdue Pharma Lp Metodos para tratar la cistitis intersticial/sindrome de dolor en la vejiga.
KR20250026332A (ko) * 2022-06-24 2025-02-25 퍼듀 퍼머 엘피 과민성 방광 증후군의 치료 또는 예방 방법

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
BE775611A (fr) 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4076717A (en) * 1971-12-15 1978-02-28 G. D. Searle & Co. Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DK162087D0 (da) * 1987-03-31 1987-03-31 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US4831192A (en) * 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5449989A (en) 1992-07-31 1995-09-12 Correa; Paulo N. Energy conversion system
US5606037A (en) 1992-11-09 1997-02-25 Biochem Pharma Inc. Processes antineoplastic heteronaphthoquinones
US5736523A (en) 1992-11-09 1998-04-07 Biochem Pharma Inc. Antineoplastic heteronapthoquinones
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5849737A (en) 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US6166085A (en) 1995-04-14 2000-12-26 The Regents Of The University Of California Method of producing analgesia
ES2247604T3 (es) * 1995-06-12 2006-03-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa.
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
WO1997024325A1 (en) 1995-12-28 1997-07-10 Takeda Chemical Industries, Ltd. DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
US6221888B1 (en) 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
EP1058684A1 (en) 1998-03-06 2000-12-13 Janssen Pharmaceutica N.V. Glycine transport inhibitors
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
ATE278674T1 (de) 1999-03-12 2004-10-15 Boehringer Ingelheim Pharma Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
WO2001021169A1 (en) 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Mch antagonists
CA2324330A1 (en) 1999-11-08 2001-05-08 Ssp Co., Ltd. 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
AU1816901A (en) 1999-12-06 2001-06-12 Euro-Celtique S.A. Benzimidazole compounds having nociceptin receptor affinity
US6486142B2 (en) 1999-12-22 2002-11-26 Merck Frosst Canada & Co. Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
US6703525B2 (en) 2000-02-16 2004-03-09 Boehringer Ingelheim Pharmaceuticals, Inc. Sulfonamide intermediates and methods of producing same
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
CA2404280A1 (en) 2000-03-24 2002-09-23 Meiji Seika Kaisha, Ltd. Diphenylalkylamine derivatives useful as opioid .delta. receptor agonists
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
JPWO2002030896A1 (ja) 2000-10-12 2004-02-19 エスエス製薬株式会社 2,2−ジフェニルブタンアミド誘導体及びこれを含有する医薬
WO2002038185A2 (en) 2000-11-13 2002-05-16 Atrix Laboratories, Inc. Injectable sustained release delivery system with loperamide
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
KR100886002B1 (ko) * 2004-01-30 2009-03-03 유로-셀띠끄 소시에떼 아노님 4-테트라졸릴-4-페닐피페리딘 화합물의 제조방법

Similar Documents

Publication Publication Date Title
JP2006525944A5 (https=)
CA2506242A1 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
RU2002107998A (ru) Сульфонилкарбоксамидные производные, способ их получения и их применение в качестве лекарственных средств
RU2001132139A (ru) Имидазохинолины с сульфонамидными или сульфамидным замещением
JP2001526269A5 (https=)
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
RU2007111758A (ru) Аминопроизводные 7- амино-3-фенилдигидропиримидо [4,5-d] пиримидинонов, их получение и применение в качестве ингибиторов протеинкиназ
JP2003500442A5 (https=)
JP2007515447A5 (https=)
RU2003137222A (ru) Замещенные амидом карбоновой кислоты производные фенилмочевины, способы их получения и их применение в качестве лекарственных средств
RU2001132570A (ru) Мочевинозамещенные имидазохинолины
RU2001132632A (ru) Производные пиперазина, применимые в качестве антагонистов CCR5
RU98120057A (ru) Производные d-пролина
JP2001526218A5 (https=)
RU95113148A (ru) Производное 2-(2-амино-1,6-дигидро-6-оксопурин-9-ил)-метокси-1,3-пропандиола
JP2007507494A5 (https=)
NO159091C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive xantinderivater.
RU2004118423A (ru) Производные бензотиазола в качестве лигандов рецептора аденозина
EP0397040A3 (en) N-heteroaryl-4-quinolinamines, a process for their preparation and their use as medicaments
RU2002133458A (ru) Соединения пиперазина и пиперидина
JP2005519885A5 (https=)
RU2007105968A (ru) Новые пиперидиновые производные для лечения депрессии
RU2004122427A (ru) Пирролидин-2-оны в качестве ингибиторов фактора ха
RU2004101229A (ru) Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения